期刊文献+

调脂治疗是收益还是风险? 被引量:1

Lipid management: is it profit or risk?
下载PDF
导出
摘要 诸多的研究结果证明了他汀类药物调脂治疗对降低心血管事件具有一定的有效性和安全性。然而,也有研究结果显示了强化调脂治疗的风险性。为尽可能发挥调脂治疗的功效又避免或减少用药的风险,可遵循生活方式干预、常规剂量给药、全面调脂治疗、个体化治疗和综合治疗等原则。 Many research results have shown the effectiveness and safety of statins lipid management in reducing cardiovascular events. However, also some research results have revealed that there are risks of the treatment. In order to develop the treatment effect and avoid or decrease the risks, such principles as the intervention of lifestyles, standardized dose of medicine, comprehensive lipid management, individualized treatments and combined treatments should be held.
作者 朱岫芳
出处 《医学争鸣》 CAS 北大核心 2014年第6期32-35,共4页 Negative
关键词 调脂治疗 他汀类 原则 lipid management statins principle
  • 相关文献

参考文献7

二级参考文献55

  • 1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:222
  • 2RIDKER PM, DANIELSON E,FONSECA FA, et al. for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein [ J]. N Engl J Med, 2008, 359(21):2195-2207.
  • 3DAHLOF B, SEVER PS, POULTER NR. for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial[J]. Lancet, 2005,366(9488) :895 -906.
  • 4COLHOUN HM, BETTERIDGE DJ, DURRINGTON PN,et al. CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study ( CARDS ) : multicentre randomised placebo-controlled trial [ J ]. Lancet, 2004,364 ( 9435 ) :685-696.
  • 5The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes[ J]. N Engl J Med,2008,358 ( 24 ) : 2545-2559.
  • 6BAIGENT C, LANDRAY MJ, REITH C,et al. SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease ( Study of Heart and Renal Protection) : a randomised placebo-controlled trial[ J]. Lancet, 2011,377(9784) :2181 -2192.
  • 7Law MR, Wald N J, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: Systematic review and recta-analysis [J]. BMJ, 2003,326 (7404) : 1423-1429.
  • 8Athyros VG, Tziomalos K, Gossios TD, et al. Safety and efficacy of long-term statin treatment for cardiovascular events inpatients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis[J]. Lancet, 2010,376 (9756) : 1916-1922.
  • 9Sharp Collaborative Group. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of loweringlow- density lipoprotein cholesterol among 9 438 patients with chronic kidney disease [J].Am Heart J, 2010,160 (5) :785- 794.
  • 10http ://www.medscape.com/viewarticle/724583.

共引文献364

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部